These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7879210)

  • 1. Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejection.
    Le Mauff B; Hourmant M; Le Meur Y; Dantal J; Cantarovich D; Caudrelier P; Alberici G; Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):865-6. PubMed ID: 7879210
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
    van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
    Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
    [No Abstract]   [Full Text] [Related]  

  • 3. Multicenter comparative study of an anti-LFA-1 adhesion molecule monoclonal antibody and antithymocyte globulin in prophylaxis of acute rejection in kidney transplantation.
    Hourmant M; Bedrossian J; Durand D; Kessler M; Le Branchu Y; Caudrelier P; Simi B; Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):864. PubMed ID: 7879209
    [No Abstract]   [Full Text] [Related]  

  • 4. Rescue of severe steroid-resistant rejection with OKT3.PAN.
    Ponticelli C; Rivolta E; Tarantino A; De Vecchi A; Vegeto A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-T12 monoclonal antibody therapy of acute renal allograft rejection.
    Milford EL; Carpenter CB; Kirkman RL; Tilney NL; Mazoujian G; Strom TB; Lazarus JM; Schlossman SF; Guttmann RD; Lowry R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1910. PubMed ID: 3274450
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody.
    Waid TH; Lucas BA; Thompson JS; Brown S; Moore D; Amlot P; Janossy G
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1778-84. PubMed ID: 2652582
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P; Kern F; Fietze E; Döcke WD; Ewert R; Emmrich F; Volk HD
    Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of macrophage subsets in renal allograft biopsies with new monoclonal antibodies.
    Burkhardt K; Sorg C; Andreesen R; Mues B; Hammer C; Land W; Gurland HJ
    Transplant Proc; 1990 Aug; 22(4):1844-5. PubMed ID: 2389457
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
    Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406
    [No Abstract]   [Full Text] [Related]  

  • 11. CD4 and CD25 monoclonal antibody cocktail in kidney transplant rejection prophylaxis: clinical results of a pilot study.
    Mousson C; Tanter Y; Racadot E; Wijdenes J; Chalopin JM; Chevet D; Hervé P; Rifle G
    Transplant Proc; 1995 Apr; 27(2):1727-8. PubMed ID: 7725472
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of interferon alpha in allograft rejection.
    Benizri EJ; Gugenheim J; Bernard G; Tovey MG
    Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
    van Gelder T; Zietse R; Yzermans JN; Rischen-Vos J; Vaessen LM; Weimar W
    Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of an anti-LFA-1 antibody in renal allograft rejection in sheep.
    Grooby WL; Carter JK; Rao MM; Dewan P; Seymour AE; Brandon M; Russ GR
    Transplant Proc; 1992 Oct; 24(5):2304. PubMed ID: 1413070
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
    Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention and reversal of renal allograft rejection by antibody against CD45RB.
    Lazarovits AI; Poppema S; Zhang Z; Khandaker M; Le Feuvre CE; Singhal SK; Garcia BM; Ogasa N; Jevnikar AM; White MH; Singh G; Stiller CR; Zhong RZ
    Nature; 1996 Apr; 380(6576):717-20. PubMed ID: 8614467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years.
    Sharma LC; Muirhead N; Lazarovits AI
    Transplant Proc; 1997; 29(1-2):323-4. PubMed ID: 9123021
    [No Abstract]   [Full Text] [Related]  

  • 18. CD45RB monoclonal antibody induces tolerance in the mouse kidney graft, but fails to prevent small bowel graft rejection.
    Zhang Z; Lazarovits A; Grant D; Garcia B; Stiller C; Zhong R
    Transplant Proc; 1996 Oct; 28(5):2514. PubMed ID: 8907929
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
    Friend PJ; Waldmann H; Hale G; Cobbold S; Rebello P; Thiru S; Jamieson NV; Johnston PS; Calne RY
    Transplant Proc; 1991 Aug; 23(4):2253-4. PubMed ID: 1908152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.